Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations

Autores
Kaufman, Teodoro Saul; Maggio, Ruben Mariano; Vignaduzzo, Silvana Edit
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
As part of the overall analytical control strategy, current regulations require stability-indicating methods (SIMs) to demonstrate product integrity until the re-test period of drug substances (DSs) or throughout the shelf life of the drug products (DPs). Accordingly, relevant topics related to SIMs (mainly for DSs but also for DPs) are critically reviewed and some recommendations are given. The development of a SIM is a process that embraces three stages; these entail obtaining suitable samples, selecting the separation technique and choosing the right detection, which also comprises method development and optimization and, finally, validating the method. The first stage yields proper knowledge of the required physicochemical properties of the DS and a deep understanding of its intrinsic stability; these are acquired through stress and accelerated testing,an approach that provides the most appropriate samples for developing SIMs. For small organic molecules, HPLC is the first choice for undertaking the second stage, which entails developing powerful separations with stability-indicating properties. In case of biologics and certain combined products, achieving analytical methods with stability-indicating properties demands a series of methods based on different, orthogonal approaches. Adequate separation of the relevant degradation products from the main analytes requires optimization of a number of chromatographic factors, including column packing, mobile phase composition, the elution mode and other variables. Evaluation of all the stability-related issues demands proper detection systems. Sophisticated hyphenated chromatographic methods are extremely useful for developing powerful SIMs; however, similar chromatographic methodologies with simpler detections are enough for routine use of the SIMs as analytical tools. Full method validation according to official guides, and demonstration of suitability of the SIM for monitoring those products actually formed, finally proves its true stability-indicating power.
Fil: Kaufman, Teodoro Saul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
Fil: Maggio, Ruben Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
Fil: Vignaduzzo, Silvana Edit. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
Materia
Degradation
Drug Assay
Drug Quality
Drug Safety
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/6003

id CONICETDig_7256d61fe920c956369d1704f4a73e5f
oai_identifier_str oai:ri.conicet.gov.ar:11336/6003
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulationsKaufman, Teodoro SaulMaggio, Ruben MarianoVignaduzzo, Silvana EditDegradationDrug AssayDrug QualityDrug Safetyhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1As part of the overall analytical control strategy, current regulations require stability-indicating methods (SIMs) to demonstrate product integrity until the re-test period of drug substances (DSs) or throughout the shelf life of the drug products (DPs). Accordingly, relevant topics related to SIMs (mainly for DSs but also for DPs) are critically reviewed and some recommendations are given. The development of a SIM is a process that embraces three stages; these entail obtaining suitable samples, selecting the separation technique and choosing the right detection, which also comprises method development and optimization and, finally, validating the method. The first stage yields proper knowledge of the required physicochemical properties of the DS and a deep understanding of its intrinsic stability; these are acquired through stress and accelerated testing,an approach that provides the most appropriate samples for developing SIMs. For small organic molecules, HPLC is the first choice for undertaking the second stage, which entails developing powerful separations with stability-indicating properties. In case of biologics and certain combined products, achieving analytical methods with stability-indicating properties demands a series of methods based on different, orthogonal approaches. Adequate separation of the relevant degradation products from the main analytes requires optimization of a number of chromatographic factors, including column packing, mobile phase composition, the elution mode and other variables. Evaluation of all the stability-related issues demands proper detection systems. Sophisticated hyphenated chromatographic methods are extremely useful for developing powerful SIMs; however, similar chromatographic methodologies with simpler detections are enough for routine use of the SIMs as analytical tools. Full method validation according to official guides, and demonstration of suitability of the SIM for monitoring those products actually formed, finally proves its true stability-indicating power.Fil: Kaufman, Teodoro Saul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; ArgentinaFil: Maggio, Ruben Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; ArgentinaFil: Vignaduzzo, Silvana Edit. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; ArgentinaElsevier2013-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/6003Kaufman, Teodoro Saul; Maggio, Ruben Mariano; Vignaduzzo, Silvana Edit; Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations; Elsevier; Trends In Analytical Chemistry; 49; 9-2013; 57-700165-9936enginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.trac.2013.05.008info:eu-repo/semantics/altIdentifier/doi/info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0165993613001428info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:52:42Zoai:ri.conicet.gov.ar:11336/6003instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:52:42.91CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
title Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
spellingShingle Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
Kaufman, Teodoro Saul
Degradation
Drug Assay
Drug Quality
Drug Safety
title_short Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
title_full Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
title_fullStr Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
title_full_unstemmed Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
title_sort Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations
dc.creator.none.fl_str_mv Kaufman, Teodoro Saul
Maggio, Ruben Mariano
Vignaduzzo, Silvana Edit
author Kaufman, Teodoro Saul
author_facet Kaufman, Teodoro Saul
Maggio, Ruben Mariano
Vignaduzzo, Silvana Edit
author_role author
author2 Maggio, Ruben Mariano
Vignaduzzo, Silvana Edit
author2_role author
author
dc.subject.none.fl_str_mv Degradation
Drug Assay
Drug Quality
Drug Safety
topic Degradation
Drug Assay
Drug Quality
Drug Safety
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv As part of the overall analytical control strategy, current regulations require stability-indicating methods (SIMs) to demonstrate product integrity until the re-test period of drug substances (DSs) or throughout the shelf life of the drug products (DPs). Accordingly, relevant topics related to SIMs (mainly for DSs but also for DPs) are critically reviewed and some recommendations are given. The development of a SIM is a process that embraces three stages; these entail obtaining suitable samples, selecting the separation technique and choosing the right detection, which also comprises method development and optimization and, finally, validating the method. The first stage yields proper knowledge of the required physicochemical properties of the DS and a deep understanding of its intrinsic stability; these are acquired through stress and accelerated testing,an approach that provides the most appropriate samples for developing SIMs. For small organic molecules, HPLC is the first choice for undertaking the second stage, which entails developing powerful separations with stability-indicating properties. In case of biologics and certain combined products, achieving analytical methods with stability-indicating properties demands a series of methods based on different, orthogonal approaches. Adequate separation of the relevant degradation products from the main analytes requires optimization of a number of chromatographic factors, including column packing, mobile phase composition, the elution mode and other variables. Evaluation of all the stability-related issues demands proper detection systems. Sophisticated hyphenated chromatographic methods are extremely useful for developing powerful SIMs; however, similar chromatographic methodologies with simpler detections are enough for routine use of the SIMs as analytical tools. Full method validation according to official guides, and demonstration of suitability of the SIM for monitoring those products actually formed, finally proves its true stability-indicating power.
Fil: Kaufman, Teodoro Saul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
Fil: Maggio, Ruben Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
Fil: Vignaduzzo, Silvana Edit. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
description As part of the overall analytical control strategy, current regulations require stability-indicating methods (SIMs) to demonstrate product integrity until the re-test period of drug substances (DSs) or throughout the shelf life of the drug products (DPs). Accordingly, relevant topics related to SIMs (mainly for DSs but also for DPs) are critically reviewed and some recommendations are given. The development of a SIM is a process that embraces three stages; these entail obtaining suitable samples, selecting the separation technique and choosing the right detection, which also comprises method development and optimization and, finally, validating the method. The first stage yields proper knowledge of the required physicochemical properties of the DS and a deep understanding of its intrinsic stability; these are acquired through stress and accelerated testing,an approach that provides the most appropriate samples for developing SIMs. For small organic molecules, HPLC is the first choice for undertaking the second stage, which entails developing powerful separations with stability-indicating properties. In case of biologics and certain combined products, achieving analytical methods with stability-indicating properties demands a series of methods based on different, orthogonal approaches. Adequate separation of the relevant degradation products from the main analytes requires optimization of a number of chromatographic factors, including column packing, mobile phase composition, the elution mode and other variables. Evaluation of all the stability-related issues demands proper detection systems. Sophisticated hyphenated chromatographic methods are extremely useful for developing powerful SIMs; however, similar chromatographic methodologies with simpler detections are enough for routine use of the SIMs as analytical tools. Full method validation according to official guides, and demonstration of suitability of the SIM for monitoring those products actually formed, finally proves its true stability-indicating power.
publishDate 2013
dc.date.none.fl_str_mv 2013-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/6003
Kaufman, Teodoro Saul; Maggio, Ruben Mariano; Vignaduzzo, Silvana Edit; Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations; Elsevier; Trends In Analytical Chemistry; 49; 9-2013; 57-70
0165-9936
url http://hdl.handle.net/11336/6003
identifier_str_mv Kaufman, Teodoro Saul; Maggio, Ruben Mariano; Vignaduzzo, Silvana Edit; Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations; Elsevier; Trends In Analytical Chemistry; 49; 9-2013; 57-70
0165-9936
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1016/j.trac.2013.05.008
info:eu-repo/semantics/altIdentifier/doi/
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0165993613001428
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083056030449664
score 13.22299